$2.89 Billion is the total value of DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s 118 reported holdings in Q1 2018. The portfolio turnover from Q4 2017 to Q1 2018 was 53.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MNKKQ | Buy | MALLINCKRODT PUB LTD CO | $124,838,000 | -4.0% | 8,621,383 | +49.5% | 4.32% | -15.5% |
| MYL | Buy | MYLAN N V | $104,906,000 | -1.0% | 2,548,111 | +1.8% | 3.64% | -12.8% |
| FIXX | New | HOMOLOGY MEDICINES INC | $97,746,000 | – | 5,227,035 | +100.0% | 3.39% | – |
| HZNP | Buy | HORIZON PHARMA PLC | $93,860,000 | +1.4% | 6,609,894 | +4.2% | 3.25% | -10.8% |
| AVXS | AVEXIS INC | $93,402,000 | +11.7% | 755,798 | 0.0% | 3.24% | -1.7% | |
| Buy | HORIZON PHARMA INVT LTDnote 2.500% 3/1 | $91,055,000 | +32.2% | 99,100,000 | +33.7% | 3.16% | +16.4% | |
| ANAB | Sell | ANAPTYSBIO INC | $82,675,000 | +1.0% | 794,338 | -2.2% | 2.86% | -11.1% |
| DBVT | Buy | DBV TECHNOLOGIES S Asponsored adr | $66,903,000 | +29.2% | 2,900,000 | +37.8% | 2.32% | +13.7% |
| CNC | New | CENTENE CORP DEL | $62,840,000 | – | 588,000 | +100.0% | 2.18% | – |
| KEMPHARM INCnote 5.500% 2/0 | $57,250,000 | +25.1% | 75,000,000 | 0.0% | 1.98% | +10.2% | ||
| MYOK | Buy | MYOKARDIA INC | $52,152,000 | +23.8% | 1,068,680 | +6.8% | 1.81% | +9.0% |
| GKOS | Sell | GLAUKOS CORP | $50,655,000 | -40.9% | 1,643,031 | -50.9% | 1.76% | -48.0% |
| DXCM | Sell | DEXCOM INC | $48,130,000 | -45.3% | 649,000 | -57.7% | 1.67% | -51.9% |
| ACRS | Buy | ACLARIS THERAPEUTICS INC | $48,105,000 | -12.7% | 2,745,705 | +22.9% | 1.67% | -23.1% |
| ISIS PHARMACEUTICALS INC DELnote 1.000%11/1 | $45,283,000 | -6.4% | 45,700,000 | 0.0% | 1.57% | -17.6% | ||
| LCI | Buy | LANNET INC | $43,994,000 | -30.2% | 2,741,077 | +0.9% | 1.52% | -38.6% |
| ANTM | Buy | ANTHEM INC | $41,963,000 | +43.5% | 191,000 | +46.9% | 1.45% | +26.3% |
| BOLD | Buy | AUDENTES THERAPEUTICS INC | $41,603,000 | +11.8% | 1,384,470 | +16.3% | 1.44% | -1.6% |
| TRINITY BIOTECH INVT LTDnote 4.000% 4/0 | $38,550,000 | -2.4% | 48,000,000 | 0.0% | 1.34% | -14.0% | ||
| EDIT | Sell | EDITAS MEDICINE INC | $38,416,000 | -26.9% | 1,158,841 | -32.2% | 1.33% | -35.6% |
| New | WRIGHT MED GROUP N Vnote 2.250%11/1 | $35,763,000 | – | 31,500,000 | +100.0% | 1.24% | – | |
| CVS | New | CVS HEALTH CORPcall | $35,261,000 | – | 566,800 | +100.0% | 1.22% | – |
| BCRX | Buy | BIOCRYST PHARMACEUTICALS | $35,138,000 | -0.8% | 7,366,460 | +2.1% | 1.22% | -12.7% |
| ENDOLOGIX INCnote 3.250%11/0 | $34,899,000 | -3.4% | 40,500,000 | 0.0% | 1.21% | -14.9% | ||
| BPMC | Sell | BLUEPRINT MEDICINES CORP | $34,750,000 | +16.4% | 378,950 | -4.3% | 1.20% | +2.5% |
| CVS | New | CVS HEALTH CORP | $34,216,000 | – | 550,000 | +100.0% | 1.18% | – |
| XENT | Sell | INTERSECT ENT INC | $32,717,000 | -31.2% | 832,500 | -43.3% | 1.13% | -39.4% |
| DVA | Buy | DAVITA INC | $32,075,000 | +4.5% | 486,427 | +14.5% | 1.11% | -8.0% |
| SEM | SELECT MED HLDGS CORP | $32,051,000 | -2.3% | 1,858,000 | 0.0% | 1.11% | -14.0% | |
| GSK | New | GLAXOSMITHKLINE PLCsponsored adr | $31,647,000 | – | 810,000 | +100.0% | 1.10% | – |
| ASND | Sell | ASCENDIS PHARMA A Ssponsored adr | $31,553,000 | -0.2% | 482,467 | -38.9% | 1.09% | -12.1% |
| NEVRO CORPnote 1.750% 6/0 | $31,273,000 | +8.2% | 27,600,000 | 0.0% | 1.08% | -4.7% | ||
| UHS | Buy | UNIVERSAL HLTH SVCS INCcl b | $31,023,000 | +107.3% | 262,000 | +98.5% | 1.08% | +82.5% |
| AGIO | Buy | AGIOS PHARMACEUTICALS INC | $29,931,000 | +99.1% | 366,000 | +39.2% | 1.04% | +75.2% |
| NTRA | Buy | NATERA INC | $29,479,000 | +12.3% | 3,180,000 | +8.9% | 1.02% | -1.2% |
| ACHC | ACADIA HEALTHCARE COMPANY IN | $29,033,000 | +20.1% | 741,016 | 0.0% | 1.01% | +5.7% | |
| INTERCEPT PHARMACEUTICALS INnote 3.250% 7/0 | $28,596,000 | -1.0% | 36,000,000 | 0.0% | 0.99% | -12.8% | ||
| AET | New | AETNA INC NEW | $27,885,000 | – | 165,000 | +100.0% | 0.97% | – |
| AVDL | Sell | AVADEL PHARMACEUTICALS PLCsponsored adr | $27,618,000 | -14.9% | 3,788,540 | -4.2% | 0.96% | -25.1% |
| ARNA | Sell | ARENA PHARMACEUTICALS INC | $27,539,000 | -46.8% | 697,194 | -54.2% | 0.95% | -53.1% |
| XNCR | Buy | XENCOR INC | $26,456,000 | +131.2% | 882,462 | +69.1% | 0.92% | +103.8% |
| AERI | AERIE PHARMACEUTICALS INC | $26,260,000 | -9.2% | 484,055 | 0.0% | 0.91% | -20.0% | |
| ARGX | Sell | ARGENX SEsponsored adr | $25,734,000 | +11.4% | 319,920 | -12.6% | 0.89% | -1.9% |
| GWPH | Sell | GW PHARMACEUTICALS PLCads | $25,402,000 | -43.3% | 225,452 | -33.5% | 0.88% | -50.1% |
| DFBHU | New | DFB HEALTHCARE ACQUISTION COunit 01/30/2023 | $25,125,000 | – | 2,500,000 | +100.0% | 0.87% | – |
| XLRN | ACCELERON PHARMA INC | $24,047,000 | -7.9% | 615,000 | 0.0% | 0.83% | -18.9% | |
| ECYT | New | ENDOCYTE INC | $23,884,000 | – | 2,627,540 | +100.0% | 0.83% | – |
| K2M GROUP HLDGS INCnote 4.125% 8/1 | $23,444,000 | +2.6% | 20,000,000 | 0.0% | 0.81% | -9.7% | ||
| WBA | Buy | WALGREENS BOOTS ALLIANCE INC | $23,307,000 | +121.3% | 356,000 | +145.5% | 0.81% | +95.2% |
| MLNT | New | MELINTA THERAPEUTICS INC | $23,146,000 | – | 3,127,846 | +100.0% | 0.80% | – |
| AIMT | New | AIMMUNE THERAPEUTICS INC | $22,606,000 | – | 710,210 | +100.0% | 0.78% | – |
| BHVN | Buy | BIOHAVEN PHARMACTL HLDG CO L | $22,385,000 | +143.3% | 869,000 | +154.8% | 0.78% | +114.4% |
| DEPOMED INCnote 2.500% 9/0 | $22,006,000 | -3.4% | 27,019,000 | 0.0% | 0.76% | -15.0% | ||
| CTMX | CYTOMX THERAPEUTICS INC | $21,432,000 | +34.8% | 753,322 | 0.0% | 0.74% | +18.7% | |
| CBIO | New | CATALYST BIOSCIENCES INC | $21,430,000 | – | 830,605 | +100.0% | 0.74% | – |
| AACH | Sell | AAC HLDGS INC | $21,284,000 | +26.2% | 1,853,998 | -1.0% | 0.74% | +11.0% |
| MCK | Sell | MCKESSON CORP | $21,131,000 | -65.7% | 150,000 | -62.0% | 0.73% | -69.8% |
| New | RADIUS HEALTH INCnote 3.000% 9/0 | $21,134,000 | – | 21,000,000 | +100.0% | 0.73% | – | |
| OXFD | Buy | OXFORD IMMUNOTEC GLOBAL PLC | $17,978,000 | +1.8% | 1,444,000 | +14.2% | 0.62% | -10.4% |
| ALNY | New | ALNYLAM PHARMACEUTICALS INC | $17,389,000 | – | 146,000 | +100.0% | 0.60% | – |
| EPZM | Sell | EPIZYME INC | $17,057,000 | +34.6% | 960,970 | -4.8% | 0.59% | +18.4% |
| SYRS | SYROS PHARMACEUTICALS INC | $16,471,000 | +33.4% | 1,268,945 | 0.0% | 0.57% | +17.5% | |
| PTLA | New | PORTOLA PHARMACEUTICALS INCput | $16,330,000 | – | 500,000 | +100.0% | 0.57% | – |
| PTLA | New | PORTOLA PHARMACEUTICALS INCcall | $16,330,000 | – | 500,000 | +100.0% | 0.57% | – |
| MNLO | New | MENLO THERAPEUTICS INC | $16,037,000 | – | 426,749 | +100.0% | 0.56% | – |
| CBAY | New | CYMABAY THERAPEUTICS INC | $15,759,000 | – | 1,213,181 | +100.0% | 0.55% | – |
| PODD | Sell | INSULET CORP | $14,822,000 | -69.6% | 171,000 | -75.8% | 0.51% | -73.2% |
| EHTH | Buy | EHEALTH INC | $14,751,000 | -16.2% | 1,030,802 | +1.7% | 0.51% | -26.3% |
| GTHX | New | G1 THERAPEUTICS INC | $13,820,000 | – | 373,000 | +100.0% | 0.48% | – |
| MOH | Sell | MOLINA HEALTHCARE INC | $13,638,000 | -68.7% | 168,000 | -70.4% | 0.47% | -72.4% |
| IMMU | Sell | IMMUNOMEDICS INC | $13,594,000 | -35.3% | 930,448 | -28.5% | 0.47% | -43.0% |
| ZBH | New | ZIMMER BIOMET HLDGS INC | $13,194,000 | – | 121,000 | +100.0% | 0.46% | – |
| AEGERION PHARMACEUTICALS INCnote 2.000% 8/1 | $13,186,000 | -0.1% | 16,600,000 | 0.0% | 0.46% | -11.9% | ||
| ARDX | Buy | ARDELYX INC | $13,144,000 | -19.4% | 2,602,733 | +5.4% | 0.46% | -29.0% |
| GLPG | GALAPAGOS NVspon adr | $12,969,000 | +6.4% | 130,000 | 0.0% | 0.45% | -6.5% | |
| SYBX | Buy | SYNLOGIC INC | $12,805,000 | +55.3% | 1,365,143 | +60.6% | 0.44% | +36.6% |
| WMGI | New | WRIGHT MED GROUP N V | $12,579,000 | – | 634,000 | +100.0% | 0.44% | – |
| RYTM | RHYTHM PHARMACEUTICALS INC | $11,582,000 | -31.5% | 582,010 | 0.0% | 0.40% | -39.8% | |
| REPH | Sell | RECRO PHARMA INC | $11,120,000 | -36.8% | 1,010,000 | -46.9% | 0.38% | -44.4% |
| New | EXACT SCIENCES CORPdbcv 1.000% 1/1 | $11,083,000 | – | 12,500,000 | +100.0% | 0.38% | – | |
| New | NUVASIVE INCnote 2.250% 3/1 | $11,001,000 | – | 10,000,000 | +100.0% | 0.38% | – | |
| WVE | Sell | WAVE LIFE SCIENCES LTD | $10,754,000 | -2.6% | 268,174 | -14.8% | 0.37% | -14.3% |
| New | IGI LABORATORIES INCnote 3.750%12/1 | $10,750,000 | – | 11,600,000 | +100.0% | 0.37% | – | |
| PFNX | Buy | PFENEX INC | $9,957,000 | +351.0% | 1,659,501 | +99.9% | 0.34% | +296.6% |
| ALLSCRIPTS HEALTHCARE SOLUTNnote 1.250% 7/0 | $9,708,000 | -6.2% | 9,671,000 | 0.0% | 0.34% | -17.4% | ||
| IVTY | Buy | INVUITY INC | $8,997,000 | +23.3% | 2,336,889 | +98.5% | 0.31% | +8.7% |
| NVTA | Buy | INVITAE CORP | $8,919,000 | -43.0% | 1,901,788 | +10.4% | 0.31% | -49.8% |
| RETA | REATA PHARMACEUTICALS INCcl a | $7,999,000 | -27.6% | 390,000 | 0.0% | 0.28% | -36.3% | |
| BIOS | BIOSCRIP INC | $7,685,000 | -15.5% | 3,124,000 | 0.0% | 0.27% | -25.7% | |
| RGNX | REGENXBIO INC | $7,651,000 | -10.2% | 256,300 | 0.0% | 0.26% | -20.9% | |
| RCKT | New | ROCKET PHARMACEUTICALS INC | $7,500,000 | – | 400,000 | +100.0% | 0.26% | – |
| ALPN | ALPINE IMMUNE SCIENCES INC | $7,305,000 | -28.6% | 913,100 | 0.0% | 0.25% | -37.1% | |
| NEOS | Buy | NEOS THERAPEUTICS INC | $7,179,000 | -5.6% | 864,906 | +16.0% | 0.25% | -16.7% |
| ARMO | New | ARMO BIOSCIENCES INC | $7,053,000 | – | 188,525 | +100.0% | 0.24% | – |
| BLUE | Sell | BLUEBIRD BIO INC | $7,001,000 | -50.9% | 41,000 | -48.8% | 0.24% | -56.7% |
| ALIM | ALIMERA SCIENCES INC | $6,235,000 | -22.5% | 6,052,935 | 0.0% | 0.22% | -31.9% | |
| MRTX | Sell | MIRATI THERAPEUTICS INC | $6,048,000 | -11.6% | 197,000 | -47.5% | 0.21% | -21.9% |
| STDY | STEADYMED LTD | $4,611,000 | -12.2% | 1,418,787 | 0.0% | 0.16% | -22.7% | |
| ALBO | New | ALBIREO PHARMA INC | $3,908,000 | – | 120,000 | +100.0% | 0.14% | – |
| SRRA | Buy | SIERRA ONCOLOGY INC | $3,653,000 | -44.4% | 1,764,889 | +0.2% | 0.13% | -51.0% |
| FOMX | Buy | FOAMIX PHARMACEUTICALS LTD | $3,458,000 | +14.8% | 674,002 | +34.5% | 0.12% | +0.8% |
| MNKD | New | MANNKIND CORP | $3,380,000 | – | 1,482,601 | +100.0% | 0.12% | – |
| PRTO | PROTEON THERAPEUTICS INC | $3,062,000 | +31.6% | 1,224,899 | 0.0% | 0.11% | +15.2% | |
| TCMD | New | TACTILE SYS TECHNOLOGY INC | $2,894,000 | – | 91,020 | +100.0% | 0.10% | – |
| EYEN | New | EYENOVIA INC | $2,745,000 | – | 300,000 | +100.0% | 0.10% | – |
| IFRX | Sell | INFLARX NV | $2,552,000 | -30.4% | 88,500 | -49.4% | 0.09% | -38.9% |
| ADVM | New | ADVERUM BIOTECHNOLOGIES INC | $2,448,000 | – | 422,000 | +100.0% | 0.08% | – |
| TSRO | TESARO INC | $2,451,000 | -31.1% | 42,893 | 0.0% | 0.08% | -39.3% | |
| ARLZ | ARALEZ PHARMACEUTICALS INC | $2,467,000 | +5.7% | 1,644,583 | 0.0% | 0.08% | -7.6% | |
| VYGR | VOYAGER THERAPEUTICS INC | $2,211,000 | +13.2% | 117,647 | 0.0% | 0.08% | 0.0% | |
| EGLTQ | New | EGALET CORP | $2,041,000 | – | 3,239,237 | +100.0% | 0.07% | – |
| RARX | Buy | RA PHARMACEUTICALS INC | $2,032,000 | +201.9% | 382,700 | +383.5% | 0.07% | +169.2% |
| TLGT | New | TELIGENT INC NEW | $1,609,000 | – | 479,000 | +100.0% | 0.06% | – |
| TNDM | New | TANDEM DIABETES CARE INC | $1,577,000 | – | 318,000 | +100.0% | 0.06% | – |
| OBLN | OBALON THERAPEUTICS INC | $1,531,000 | -48.1% | 446,284 | 0.0% | 0.05% | -54.3% | |
| SCYX | New | SCYNEXIS INC | $1,367,000 | – | 1,020,000 | +100.0% | 0.05% | – |
| SIEN | New | SIENTRA INC | $1,063,000 | – | 110,000 | +100.0% | 0.04% | – |
| KIDS | ORTHOPEDIATRICS CORP | $877,000 | -21.6% | 58,247 | 0.0% | 0.03% | -31.8% | |
| NCNA | Exit | NUCANA PLCsponsored adr | $0 | – | -82,637 | -100.0% | -0.03% | – |
| AKTX | Exit | AKARI THERAPEUTICS PLCsponsored adr | $0 | – | -249,785 | -100.0% | -0.04% | – |
| ASNS | Exit | ARSANIS INC | $0 | – | -131,548 | -100.0% | -0.07% | – |
| MDXG | Exit | MIMEDX GROUP INC | $0 | – | -150,000 | -100.0% | -0.07% | – |
| EIGR | Exit | EIGER BIOPHARMACEUTICALS INC | $0 | – | -300,000 | -100.0% | -0.16% | – |
| PTGX | Exit | PROTAGONIST THERAPEUTICS INC | $0 | – | -225,000 | -100.0% | -0.18% | – |
| ALNA | Exit | ALLENA PHARMACEUTICALS INC | $0 | – | -605,100 | -100.0% | -0.24% | – |
| MCK | Exit | MCKESSON CORPcall | $0 | – | -43,200 | -100.0% | -0.26% | – |
| DCPH | Exit | DECIPHERA PHARMACEUTICALS IN | $0 | – | -336,009 | -100.0% | -0.30% | – |
| FPRX | Exit | FIVE PRIME THERAPEUTICS INC | $0 | – | -450,728 | -100.0% | -0.39% | – |
| APLS | Exit | APELLIS PHARMACEUTICALS INC | $0 | – | -513,000 | -100.0% | -0.44% | – |
| LOXO | Exit | LOXO ONCOLOGY INC | $0 | – | -169,000 | -100.0% | -0.56% | – |
| PTLA | Exit | PORTOLA PHARMACEUTICALS INC | $0 | – | -298,545 | -100.0% | -0.57% | – |
| Exit | AMAG PHARMACEUTICALS INCnote 3.250% 6/0 | $0 | – | -25,250,000 | -100.0% | -0.86% | – | |
| EVHC | Exit | ENVISION HEALTHCARE CORP | $0 | – | -676,000 | -100.0% | -0.92% | – |
| RVNC | Exit | REVANCE THERAPEUTICS INC | $0 | – | -1,000,000 | -100.0% | -1.41% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AERIE PHARMACEUTICALS INC | 36 | Q3 2022 | 3.6% |
| CENTENE CORP DEL | 30 | Q3 2023 | 3.0% |
| BIOCRYST PHARMACEUTICALS INC | 29 | Q3 2023 | 2.2% |
| MOLINA HEALTHCARE INC | 26 | Q3 2022 | 1.7% |
| EHEALTH INC | 25 | Q3 2020 | 2.0% |
| INTERCEPT PHARMACEUTICALS IN | 24 | Q1 2023 | 2.2% |
| MYLAN NV | 23 | Q3 2020 | 6.2% |
| PORTOLA PHARMACEUTICALS INC | 23 | Q1 2019 | 6.0% |
| BROOKDALE SR LIVING INC | 23 | Q3 2023 | 2.2% |
| ALIMERA SCIENCES INC | 23 | Q3 2019 | 0.8% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| DA32 Life Science Tech Acquisition Corp. | August 01, 2023 | 5,145,000 | 91.1% |
| CareMax, Inc. | March 13, 2023 | 18,691,423 | 16.4% |
| CareMax, Inc. | June 02, 2022 | 18,691,423 | 20.7% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 3 | 2024-03-19 |
| 4 | 2024-03-19 |
| 4 | 2024-03-12 |
| 3 | 2024-03-08 |
| 4 | 2024-02-16 |
| 13F-HR | 2024-02-14 |
| 4 | 2024-02-08 |
| 3 | 2024-02-01 |
| 4 | 2023-11-21 |
| 13F-HR | 2023-11-14 |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.